This company has all the right stuff and is on track to executing its business model. Formulating System LS for weight control and nourishment is the company's primary product. Distribution agreements with Super Health Center and GNC have driven revenues

A superior management team is at the helm . Revenues are expanding rapidly year .The company has applied to the QTCQX.

In a recent interview with management ( Podcast ) , the company has a three pronged strategy for significant future growth .

1)  Expanding into other countries as well as expansion in Australia
2)  Increase distribution partnerships
3)  Strategic Acquisitions

We urge all serious investors to place these shares on their BUY LIST


Listen To Podcast

The Company generated revenue of $1.78m (H1 FY2019: $0.78m) in the period under review and continues to progress its strategy of bringing to market new products, across multiple categories, which it believes will anchor the future earnings of the business.

An increase of 229% as the Company secured two significant sales contracts from GNC & Sigma which form the solid platform for top-line revenue objectives.  Despite the retail headwinds in North America & Australia, sales for the period have grown considerably, driven predominantly by the SystemLS brand.  

The second half of the year has begun strongly through the retail channels and the company continues to expand its global distribution footprint and has entered discussions with a well-established African based healthcare company.

The company’s Direct to Consumer channel strategy through its partnership with Streamcast Marketing is anticipated to expand considerably with a major brand launch of SystemLS scheduled this quarter, driving incremental revenue and increased margins in the second half of the financial year.

Through the company’s global logistics partner Super Health Center (“SHC”) has presented the company’s flagship brand to key retailers in the UK and the Middle East with in-market visits.  The response has been encouraging and initial orders are also expected in this quarter.

Rapid Nutrition CEO Simon St. Ledger stated, “The Board believes there are significant opportunities to grow the business organically and through acquisitions.  Our focus in FY2020 will be based around these initiatives to generate further growth over the long term. We expect the second half of the year to be disproportionally higher than in previous years given the phasing of our substantially wider distribution network and we remain confident that this will be a year of substantial growth across the business.”

The group’s half-year report will be published March 30th, 2020.

About Rapid Nutrition

Rapid Nutrition is a natural healthcare company focused on the research, development, and production of a range of life science products. The company was established based on its successful and proven weight loss supplement range which is exported worldwide and now offers consumers a growing range of health and well-being solutions to meet existing and emerging societal health concerns, as well as a providing a number of wider services to the life sciences industry. For more information, please visit http://rnplc.com

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Rapid PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.

Neither PSN nor its owners, members, officers, directors, partners, consultants, nor anyone involved in the publication of this website, is a registered investment adviser or broker-dealer or associated person with a registered investment adviser or broker-dealer and none of the foregoing make any recommendation that the purchase or sale of securities of any company profiled in the PSN website is suitable or advisable for any person or that an investment or transaction in such securities will be profitable. The information contained in the PSN website is not intended to be, and shall not constitute, an offer to sell nor the solicitation of any offer to buy any security. The information presented in the PSN website is provided for informational purposes only and is not to be treated as advice or a recommendation to make any specific investment. Please consult with an independent investment adviser and qualified investment professional before making an investment decision.